Similar beneficial effects have been found by another research group, who found that chronic administration of the amylin analog pramlintide, which lacks amyloidogenic properties, improved AD-related neuropathological and cognitive deficits in SAMP8 mice, a genetic mouse model of sporadic AD (Adler et al., 2014). Here, IAPP is linked to Cognitive impairment.